BioStem Technologies, Inc. (BSEM) vs Edesa Biotech, Inc. (EDSA)
A side-by-side comparison of BioStem Technologies, Inc. and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT
EDSA
Edesa Biotech, Inc.
$3.83HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
Total return — BSEM vs EDSA
growth of $100 · dividends reinvested · last 10yBSEM -72.4% (-12.1%/yr)EDSA -99.4% (-40.3%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM EDSA
BSEM vs EDSA: by the numbers
- •BSEM is the larger company ($44M vs $37M market cap).
- •Both run net losses; EDSA's is the smaller (0.00% vs -13.86% net margin).
Metrics side by side
Valuation
| Metric | BSEM | EDSA |
|---|---|---|
| P/B ratio | 1.58 | 92.53 |
Profitability
| Metric | BSEM | EDSA |
|---|---|---|
| Gross margin | 93.13% | 0.00% |
| Operating margin | -1.45% | 0.00% |
| Net margin | -13.86% | 0.00% |
| ROE | -102.45% | -160.05% |
| ROIC | -80.92% | -166.02% |
Growth (annualized)
| Metric | BSEM | EDSA |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | -39.88% |
Frequently asked
- How have BSEM and EDSA total returns compared?
- Over the past 10 years, BSEM delivered -12.08% and EDSA delivered -40.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.